Long-term follow-up of aortic involvement in giant cell Arteritis: A series of 48 patients

Medicine

Volumn 88, Issue 3, 2009, Pages 182-192

  Marie, Isabelle ^a   Proux, Alice ^a   Duhaut, Pierre ^b   Primard, Etienne ^a   Lahaxe, Laure ^a   Girszyn, Nicolas ^a   Louvel, Jean Pierre ^a   Levesque, Hervé ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; FLUORODEOXYGLUCOSE F 18; HEMOGLOBIN; PREDNISONE; STEROID;

ABDOMINAL PAIN; ADULT; AGED; AORTA ANEURYSM; AORTA ARCH SYNDROME; AORTA DISEASE; AORTA WALL; AORTITIS; ARTICLE; ASTHENIA; BRAIN ISCHEMIA; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FOLLOW UP; GIANT CELL ARTERITIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; INFECTION; LOW BACK PAIN; LOW DRUG DOSE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STEROID THERAPY; AORTA; FRANCE; MIDDLE AGED; PATHOLOGY; PREVALENCE; TIME;

AGED; AGED, 80 AND OVER; AORTA; FEMALE; FRANCE; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; PREVALENCE; RETROSPECTIVE STUDIES; TAKAYASU ARTERITIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66349131353     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181a68ae2     Document Type: Article

References (72)

1. Agard C, Barrier JH, Dupas B, Ponge T, Mahr A, Fradet G, Chevalet P, Masseau A, Batard E, Pottier P, Planchon B, Brisseau JM, Hamidou MA. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670-676.
2. Andersson R, Malmvall BE, Bengtsson BA. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids. Acta Med Scand. 1986;220:361-364.
3. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med. 2004;116:50-53.
4. Bley TA, Wieben O, Uhl M, Miehle N, Langer M, Hennig J, Markl M. Integrated head-thoracic vascular MRI at 3 T: assessment of cranial, cervical and thoracic involvement of giant cell arteritis. MAGMA. 2005;18:193-200.
5. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol. 2009;21:19-28.
6. Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, De Ceuninck L, Marchal G, Bobbaers H. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford). 2008;47: 1179-1184.
7. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131-137.
8. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-249.
9. Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18:10Y17.
10. Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, Gross WL, Heller M, Bahre M. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis. 2008;67:1030-1033.
11. Cambria RA, Gloviczki P, Stanson AW, Cherry KJ, Bower TC, Hallett JW, Pairolero PC. Outcome and expansion rate of 57 thoracoabdominal aortic aneurysms managed nonoperatively. Am J Surg. 1995;170:213-217.
12. Chatelain D, Duhaut P, Schmidt J, Loire R, Bosshard S, Guernou M, Pellet H, Piette JC, Sevestre H, Ducroix JP; Groupe de Recherche sur l'Arterite a' Cellules Geantes. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Ann Rheum Dis. 2009;68:84-88.
13. Costello JM Jr, Nicholson WJ. Severe aortic regurgitation as a late complication of temporal arteritis. Chest. 1990;98:875-877.
14. Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Disease of the Heart and Great Vessels. 9th ed. Boston: Little, Brown; 1994.
15. de Leeuw K, Bijl M, Jager PL. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol. 2004;22(6 Suppl 36): S21-S26.
16. Eklund E, Englund E, Valdemarsson S. Rupture of a non-aneurysmatic aortic trunk in a patient with giant cell arteritis. Ann Rheum Dis. 1998;57:442-443.
17. Evans JM, Bowles CA, Bjornsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum. 1994;37:1539-1547.
18. Evans J, Hunder GG. The implications of recognizing large-vessel involvement in elderly patients with giant cell arteritis. Curr Opin Rheumatol. 1997;9:37-40.
19. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995;122:502-507.
20. Fernandez-Lopez MJ, Wamen SA, Karmali R, Peretz A, Gonzalez-Gay MA, Bentin J. Low back pain as presenting manifestation of giant cell arteritis associated to abdominal aortitis. Clin Exp Rheumatol. 2007;25(suppl 44):S31-S33.
21. Gelsomino S, Romagnoli S, Gori F, Nesi G, Anichini C, Sorbara C, Stefano P, Gensini GF. Annuloaortic ectasia and giant cell arteritis. Ann Thorac Surg. 2005;80:101-105.
22. Gonzalez-Gay MA. The diagnosis and management of patients with giant cell arteritis. J Rheumatol. 2005;32:1186-1188.
23. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84:269-276.
24. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998;41: 1497-1504.
25. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain. A population-based study. Medicine (Baltimore). 2004;83:335-341.
26. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, Llorca J. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83: 342-347.
27. Hautzel H, Sander O, Heinzel A, Schneider M, Muller HW. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med. 2008;49:1107-1113.
28. Hellmann DB. Low-dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum. 2004;50:1026-1027.
29. Henes JC, Muller M, Krieger J, Balletshofer B, Pfannenberg AC, Kanz L, Kotter I. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol. 2008;26(3 suppl 49):S47-S52.
30. Herve F, Choussy V, Janvresse A, Cailleux N, Levesque H, Marie I. Aortite inflammatoire et maladie de Horton. A propos du suivi evolutif scanographique prospectif d'une serie de 11 patients. Rev Med Interne. 2006;27:196-202.
31. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33: 1122-1228.
32. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis. A 25-year epidemiological, clinical and pathologic study. Ann Intern Med. 1978;88:162-167.
33. Janssen SP, Comans EH, Voskuyl AE, Wisselink W, Smulders YM. Giant cell arteritis: heterogeneity in clinical presentation and imaging results. J Vasc Surg. 2008;48:1025-1031.
34. Kay RH, Pooley R, Herman MV Unsuspected giant cell arteritis diagnosed at open heart surgery. Arch Intern Med. 1982;142: 1378-1379.
35. Kerr LD, Chang YJ, Spiera H, Fallon JT. Occult active giant cell aortitis necessitating surgical repair. J Thorac Cardiovasc Surg. 2000;120:813-815.
36. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975;83:806-812.
37. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol. 2002;14:3-10.
38. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24:422-431.
39. Liu G, Shupak R, Chiu BKY Aortic dissection in giant-cell arteritis. Semin Arthritis Rheum. 1995;25:160-11.
40. Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Pena-Sagredo JL, Martin J, Gonzalez-Gay MA. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum. 2008;38:116-123.
41. Masuda Y, Takanashi K, Takasu J, Aoyagi Y, Morooka N, Watanabe S, Inagaki Y Unoperated thoracic aortic aneurysms: survival rates of the patients and determinants of prognosis. Intern Med. 1992;31: 1088-1093.
42. Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, Conrad M, Vosshenrich R. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003;30: 730-736.
43. Mitnick HJ, Tunick PA, Rotterdam H, Esposito R. Antemortem diagnosis of giant cell aortitis. J Rheumatol. 1990;17:708-711.
44. Narvaez J, Narvaez JA, Nolla JM, Sirvent E, Reina D, Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford). 2005;44:479-483.
45. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50:1332-1337.
46. Nesi G, Anichini C, Pedemonte E, Tozzini S, Calamai G, Montesi GF, Gori F Giant cell arteritis presenting with annuloaortic ectasia. Chest. 2002;121:1365-1367.
47. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford). 2003;42:413-421.
48. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-3531.
49. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532-3537.
50. Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand. 1973;237(Suppl):1-59.
51. Ostberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis. 1971;30:224-235.
52. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403-408.
53. Richardson MP, Lever AM, Fink AM, Dixon AK, Hazleman BL. Survival after aortic dissection in giant cell arteritis. Ann Rheum Dis. 1996;55:332-333.
54. Rojo-Leyva F, Ratliff NB, Cosgrove DM III, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43:901-907.
55. Salisbury RS, Hazleman BL. Successful treatment of dissecting aortic aneurysm due to giant cell arteritis. Ann Rheum Dis. 1981;40: 507-508.
56. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
57. Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiardi L. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford). 2009;48:250-253.
58. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123:192-194.
59. Save-Soderbergh J, Malmvall BE, Andersson R, Bengtsson BA. Giant cell arteritis as a cause of death. Report of nine cases. JAMA. 1986;255:493-496.
60. Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol. 2000;18(suppl 20):S43-S48.
61. Staunton H, Stafford F, Leader M, O'Riordain D. Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol. 2000;57:581-584.
62. Turlakow A, Yeung HW, Pui J, Macapinlac H, Liebovitz E, Rusch V, Goy A, Larson SM. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med. 2001;161:1003-1007.
63. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002;29:737-742.
64. Walter MA. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am. 2007;45:735-744.
65. Walter MA, Melzer RA, Graf M, Tyndall A, Muller-Brand J, Nitzsche EU. [18F]FDG-PET of giant-cell aortitis. Rheumatology (Oxford). 2005;44:690-691.
66. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU. The value of [18FJFDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674-681.
67. Warrington KJ, Matteson EL. Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol. 2007;25(suppl 47):S137-S141.
68. Weyand CM, Bartley GB. Giant cell arteritis: new concepts in pathogenesis and implications for management. Am J Ophthalmol. 1997;123:392-395.
69. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum. 1999;42:844-853.
70. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139:505-515.
71. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26:314-319.
72. Zehr KJ, Mathur A, Orszulak TA, Mullany CJ, Schaff HV. Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg. 2005;79:1512-1517.